Cellect Biotechnology Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cellect Biotechnology Ltd. generated cash of -$20,337,000, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$20,445,000.
Cash Flow
| 2016 | -14.41M | -18.01M | 0 |
|---|---|---|---|
| 2017 | -17.77M | 10.09M | 0 |
| 2018 | -23.63M | 13.70M | 0 |
| 2019 | -20.33M | -108K | 0 |
APOP Cash Flow Statement (2016 – 2019)
| 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|
Cash at beginning of period | 0 | 0 | 0 | 0 |
Operating activities | ||||
Net income | 16.80M | 0 | 28.22M | 15.31M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 433K | 459K | 372K | 350K |
Stock-based compensation expense | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 385K | 43K | 470K | -1.04M |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -20.33M | -23.63M | -17.77M | -14.41M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -123K | -656K | -266K | -1.26M |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -108K | 13.70M | 10.09M | -18.01M |
Financing activities | ||||
Common Stock Issued | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 |
Cash used in financing activities | 0 | 0 | 0 | 0 |
Net Change In Cash | -20.44M | -9.92M | -7.67M | -32.42M |
Cash at end of period | -20.44M | -9.92M | -7.67M | -32.42M |
| Data source | Data source | Data source | Data source |